HBx is a hepatitis B viral protein. It is 154 amino acids long and interferes with transcription, signal transduction, cell cycle progress, protein degradation, apoptosis and chromosomal stability in the host. It forms a heterodimeric complex with its cellular target protein (HBX interacting protein: HBXIP), and this interaction dysregulates centrosome dynamics and mitotic spindle formation. It interacts with DDB1 (Damaged DNA Binding Protein 1) redirecting the ubiquitin ligase activity of the CUL4-DDB1 E3 complexes, which are intimately involved in the intracellular regulation of DNA replication and repair, transcription and signal transduction.
Transgenic mice expressing the X protein in liver are more likely than the wild type to develop hepatocellular carcinoma. This is because the X protein promotes cell cycle progression while binding to and inhibiting tumor suppressor protein p53 from performing their role. Experimental observations also suggest that HBx protein increases TERT and telomerase activity, prolonging the lifespan of hepatocytes and contributing to malignant transformation.
Molecular effects of HBx
HBx causes many cellular alterations. These alterations are due to direct actions of HBx and indirect actions due to large increases in intracellular reactive oxygen species (ROS) partly induced by HBx. HBx appears to dysregulate a number of cellular pathways. HBx causes dysregulation by binding to genomic DNA, changing expression patterns of miRNAs, affecting histone methyltransferases, binding to SIRT1 protein to activate transcription, and cooperating with histone methylases and demethylases to change cell expression patterns.
HBx is partly responsible for the approximate 10,000-fold increase in intracellular ROS upon chronic HBV infection. HBx can localize to the mitochondria where HBx decreases the mitochondrial membrane potential and causes increased release of ROS. In addition, other HBV proteins, HBsAg and HBcAg, also increase ROS through interactions with the endoplasmic reticulum. ROS cause more than 20 types of DNA damage. Oxidative DNA damage is mutagenic.
HBx has large effects on the transcription levels of many genes. In a transgenic mouse model expressing the HBx gene of hepatitis B virus (but not other HBV genes), most mice developed hepatic tumors. In these HBx transgenic mice there were 10,553 differentially DNA methylated regions (6,668 hypermethylated and 3,885 hypomethylated regions). In mammalian cells, large clusters of CpG dinucleotides known as CpG islands (CGIs) appear to act as key epigenetic elements regulating gene expression. Hyper-methylation of the CGIs in promoters can silence genes, while hypo-methylation of CGIs within distal exons of genes can also repress transcription of genes. A large proportion of the methylation alterations in the HBx transgenic mice were at CGIs. HBx especially induced hypo-methylation of distal intragenic CGIs required for active expression. There were 647 genes containing intragenic CGIs that were hypo-methylated in HBx transgenic mouse liver.
HBx also directly interacts with many genes. Several thousand protein-coding genes appear to have HBx-binding sites. In addition to binding to protein coding genes, HBx bound to the promoters controlling 15 microRNAs and 16 Long non-coding RNAs. For the 15 miRNAs with promoters bound by HBx, expression levels increased for eight, decreased for 5, and did not change significantly for two. Each microRNA with altered level of expression can affect the expression of several hundred messenger RNAs (see microRNA).
Relation to PRMT1
In a study purifying cancerous liver cells infected with HBV, the level of expression of protein arginine methyltransferase 1 (PRMT1) was found to be associated with changes in transcription due to the methyltransferase function of PRMT1. Overexpression causes a reduction in the number of HBV genes transcribed, while conversely, underexpression causes an increase. PRMT1 was also found to be recruited by HBV DNA during the replication process to regulate the transcription process. Increased HBx expression in turn leads to an inhibition of PRMT1-mediated protein methylation, benefiting viral replication.
- McClain SL, Clippinger AJ, Lizzano R, Bouchard MJ (November 2007). "Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels". J. Virol. 81 (21): 12061–5. doi:10.1128/JVI.00740-07. PMC 2168786. PMID 17699583.
- Bouchard MJ, Puro RJ, Wang L, Schneider RJ (July 2003). "Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication". J. Virol. 77 (14): 7713–9. doi:10.1128/JVI.77.14.7713-7719.2003. PMC 161925. PMID 12829810.
- Wen, Y.; Golubkov, VS.; Strongin, AY.; Jiang, W; Reed, J.C. (2008). "Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation". Journal of Biological Chemistry. 283 (5): 2793–2803. doi:10.1074/jbc.M708419200. PMID 18032378.
- Li, T; Robert, E.I.; van Breugel, P.C.; Strubin, M.; Zheng, N. (2010). "A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery". Nature Structural & Molecular Biology. 17 (1): 105–111. doi:10.1038/nsmb.1719. PMC 2823288. PMID 19966799.
- Lin, B.; Anderson, D.A. (2000). "A vestigial X open reading frame in duck hepatitis B virus". Intervirology. 43 (3): 185–190. doi:10.1159/000025037. PMID 11044813.
- van Hemert, F.J.; van de Klundert, M.A.; Lukashov, V.V.; Kootstra, N.A.; Berkhout, B.; Zaaijer, H.L. (2011). "Protein x of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylase". PLoS ONE. 6 (8): e23392. doi:10.1371/journal.pone.0023392. PMC 3153941. PMID 21850270.
- Kew, M.C. (2011). "Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma". Journal of Gastroenterolology and Hepatology. 26 (Suppl 1): 144–152. doi:10.1111/j.1440-1746.2010.06546.x. PMID 21199526.
- Balakrishnan L, Milavetz B (2017). "Epigenetic Regulation of Viral Biological Processes". Viruses. 9 (11): 346. doi:10.3390/v9110346. PMC 5707553. PMID 29149060.
- Valgimigli M, Valgimigli L, Trerè D, Gaiani S, Pedulli GF, Gramantieri L, Bolondi L (2002). "Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation". Free Radic. Res. 36 (9): 939–48. doi:10.1080/107156021000006653. PMID 12448819.
- Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG (2017). "Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis". Oncotarget. 8 (3): 3895–3932. doi:10.18632/oncotarget.13904. PMC 5354803. PMID 27965466.
- Higgs MR, Chouteau P, Lerat H (2014). "'Liver let die': oxidative DNA damage and hepatotropic viruses". J. Gen. Virol. 95 (Pt 5): 991–1004. doi:10.1099/vir.0.059485-0. PMID 24496828.
- Yu Y, Cui Y, Niedernhofer LJ, Wang Y (2016). "Occurrence, Biological Consequences, and Human Health Relevance of Oxidative Stress-Induced DNA Damage". Chem. Res. Toxicol. 29 (12): 2008–2039. doi:10.1021/acs.chemrestox.6b00265. PMC 5614522. PMID 27989142.
- Dizdaroglu M (2012). "Oxidatively induced DNA damage: mechanisms, repair and disease". Cancer Lett. 327 (1–2): 26–47. doi:10.1016/j.canlet.2012.01.016. PMID 22293091.
- Lee SM, Lee YG, Bae JB, Choi JK, Tayama C, Hata K, Yun Y, Seong JK, Kim YJ (2014). "HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators". Proc. Natl. Acad. Sci. U.S.A. 111 (26): 9555–60. doi:10.1073/pnas.1400604111. PMC 4084425. PMID 24941955.
- Guerrieri F, Belloni L, D'Andrea D, Pediconi N, Le Pera L, Testoni B, Scisciani C, Floriot O, Zoulim F, Tramontano A, Levrero M (2017). "Genome-wide identification of direct HBx genomic targets". BMC Genomics. 18 (1): 184. doi:10.1186/s12864-017-3561-5. PMC 5316204. PMID 28212627.
- Benhenda S; Ducroux A; Rivière L; Sobhian B; Ward MD; Dion S; Hantz O; Protzer U; Michel ML; Benkirane M; Semmes OJ; Buendia MA; Neuveut C (2013). "Methyltransferase PRMT1 Is a Binding Partner of HBx and a Negative Regulator of Hepatitis B Virus Transcription". Journal of Virology. 87 (8): 4360–4371. doi:10.1128/JVI.02574-12. PMC 3624337. PMID 23388725.